Skip to main content
TOVX logo
TOVX
(NYSEAMERICAN)
Theriva Biologics, Inc.
$0.22-- (--)
Loading... - Market loading

Theriva Biologics (TOVX) Stock Price & Financial Analysis

Theriva Biologics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.20 - $0.23
52-Week High$0.86
52-Week Low$0.16
Open$0.23
Volume606.87K
Average Volume (3M)11.83M
Market Cap9.37M
Shares Outstanding41.07M
Price to Sales (P/S)31.27
Price to Book (P/B)0.61
EV/EBITDA0.06
Revenue (TTM)300.00K
Net Income (TTM)-21.46M
Free Cash Flow (TTM)-14.40M
EPS (TTM)$-1.23
Profit Margin-7153.00%
Operating Margin-7245.00%
Return on Equity (ROE)-139.35%
Debt to Equity0.24
50-Day MA$0.28
200-Day MA$0.26
52-Week Change-52.12%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateDec 27, 2007

Frequently Asked Questions About Theriva Biologics

What is the current stock price for TOVX?

As of the latest trading session, TOVX stock trades at $0.22. The 52-week range is $0.16–$0.86, with a day range of $0.20–$0.23.

What is the P/E ratio for TOVX?

The P/E ratio (Price-to-Earnings) for TOVX is shown in the Key Statistics section. This valuation metric helps compare Theriva Biologics, Inc. to industry peers.

Does TOVX pay dividends?

Theriva Biologics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TOVX?

Analyst ratings and recommendations for TOVX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of TOVX?

Theriva Biologics's market capitalization is $8.9M, classifying it as a micro-cap company. Theriva Biologics operates in the Healthcare sector within the Biotechnology industry.